Lindsey Yourman, associate clinical professor in the division of geriatrics, gerontology, and palliative care at the University of California San Diego School of Medicine
In terms of scalability and access, orforglipron may have a logistical advantage, even if it hits the market slightly later
Beyond weight loss and diabetes management, recent studies suggest GLP-1 drugs may offer other health benefits, too from treating addiction to lowering the risk of dementia
Brief Zofran Litigation History By December 2015, more than 150 Zofran lawsuits had been centralized in the U.S
Citrus, cinnamon, and mint flavors often work well
Both the lifestyle interventions group and metformin group had no increased risk of adverse effects compared to placebo [9]